Childrens Hospital of Los Angeles
LoginEn EspanolSite Search
  • Home
  • Patients & Families
  • Research
  • Giving
  • Healthcare Professionals

The Saban Research
Institute
....................................................
Our Faculty
....................................................
Programs and Institutes
....................................................
Careers and Education
....................................................
Core Services
....................................................
Office of Technology
Transfer
....................................................
Annual Report
....................................................

   The Saban Research
    Institute Periodical 

   

Technology Available for Licensing

Quicklinks

Bioinformatics
Cancer Treatment Agents
Cardiovascular & Pulmonary Hypertension
Developmental Biology Diagnostic Tests
DIMSCAN: automated technology for screening anti-cancer agents
Non-Invasive Real-Time Analyte Monitoring
Research Tools
Stem Cell Biology and Gene Therapy
Tissue Repair and Regeneration 


Inquiries

   Contact:  Jessica Rousset
   Director, Technology Transfer  
   (323) 361-4531

Bioinformatics

Childrens Hospital Los Angeles Ref. Number: 2007-002
Title: Sparse representation and Bayesian detection of genome copy number changes from array data
Principal Investigator:  Dr. Shahab Asgharzadeh 
Detailed non-confidential summary

Cancer Treatment Agents

Childrens Hospital Los Angeles Ref. Number: 008.0
Title: Fenretinide Combinations
Principal Investigators: 
Patrick Reynolds , Barry Maurer
Patents: 6,352,8446,368,831 , CA, EP, JP, BR, CN, HK, IN, MX
Detailed non-confidential summary

Childrens Hospital Los Angeles Ref. Number: 028.0
Title: PPMP Use and Composition of Matter
Principal Investigators: Patrick Reynolds , Barry Maurer
Patents: 10/712,763
Detailed non-confidential summary

Childrens Hospital Los Angeles Ref. Number: 022.0
Title: Fenretinide Compositions with Increased Bioavailability and Ease of Administration
Principal Investigators: Patrick Reynolds , Barry Maurer
Patents: 10/010,914 , EP, JP
Detailed non-confidential summary

Childrens Hospital Los Angeles Ref. Number: 025.0
Title: Pharmaceutical Compositions of Safingol and Methods of Using the Same
Principal Investigators: Patrick Reynolds , Barry Maurer
Patents: 10/782,459 , CA, JP, MX, EP (DE, IT, UK, FR, FP)
Detailed non-confidential summary

Childrens Hospital Los Angeles Ref. Number: 027.0
Title: Lym-X-Sorb Powder Formulations
Principal Investigators: Patrick Reynolds , Barry Maurer
Patents: 10/767,35211/170,37111/170,561 , JP, MX, EP, CA
Detailed non-confidential summary

Cardiovascular and Pulmonary Hypertension

Childrens Hospital Los Angeles Ref. Number: 019.0
Title: Methods of facilitating vascular growth in cardiac muscle and methods for the production of recombinant EMAP II. 
Principal Investigator: Margaret Schwarz
Patents: US Application No. 09/733,306
Detailed non-confidential summary

Childrens Hospital Los Angeles Ref. Number: 018.0
Title: Methods and pharmaceutical formulations for the treatment of pulmonary hypertension and methods for screening compounds useful in the treatment of pulmonary hypertension
Principal Investigator(s): Margaret Schwarz
Patents: US Application 10/274,788 , CA, EP
Detailed non-confidential summary

Childrens Hospital Los Angeles Ref. Number: 010.0
Title: Methods for Facilitating Vascular Growth
Principal Investigator(s): 
Margaret Schwarz
Patents: US Patent # 6,306,612US Patent #6,857,749 , AU, CA, EP, JP
Detailed non-confidential summary

Developmental Biology, Tissue Repair and Regeneration

Childrens Hospital Los Angeles Ref. Number: 024.0
Title: Treatment and prevention of abnormal scar formation
Principal Investigator(s): Tai-Lan Tuan and David Warburton
Patents: US application No. 10/439,267 , JP, EP, BR, SG, CN
Detailed non-confidential summary

Childrens Hospital Los Angeles Ref. Number: Title: Bone Morphogenic Protein (BMP) inhibitor for use in regulating important developmental and disease processes
Principal Investigator(s): Wei Shi and David Warburton
Patents: PCT application filed

Detailed non-confidential summary

Diagnostic Tests

Childrens Hospital Los Angeles Ref. Number: 2007-001
Title: Molecular Diagnosis of Brain Glial Tumors
Principal Investigator: Dr. Hae-Ri Song
Detailed non-confidential summary

Childrens Hospital Los Angeles Ref. Number: 2007-004
Title: Mitochondrial DNA polymorphisms are associated with functional disease
Principal Investigator: Richard Boles
Non-confidential summary

DIMSCAN: automated technology for screening anti-cancer agents

Childrens Hospital Los Angeles Ref. Number: 005.0
Title: Fluorescence Digital Imaging Microscopy System
Principal Investigator: Patrick Reynolds
Patents: 08/622,1106,459,8056,665,430
Detailed non-confidential summary
Mol Cancer Ther2007;6(3). March 2007 

Non-Invasive Real-Time Analyte Monitoring

Childrens Hospital Los Angeles Ref. Number: 007.0
Title: Non-Invasive Glucose Monitor
Principal Investigator: Mark Borchert
Patents: 6,181,9576,424,850 , CA, MX, EP
Detailed non-confidential summary

Childrens Hospital Los Angeles Ref. Number: 023.0
Title: Non-Invasive Identification and Measurement of Selected Toxins or Substances in the Human Body
Principal Investigator: Mark Borchert
Patents: 6,574,5016,961,59910/396,035 , CA, EP
Detailed non-confidential summary

Childrens Hospital Los Angeles Ref. Number: 006.0
Title: Non-Invasive Intracranial Pressure Monitor
Principal Investigator: Mark Borchert
Patents: 6,129,682 , JP
Detailed non-confidential summary

Childrens Hospital Los Angeles Ref. Number: 026.0
Title: Measurement of Macular Pigments
Principal Investigator: Mark Borchert
Patents: 10/773,099 , CA, EP
Detailed non-confidential summary

Childrens Hospital Los Angeles Ref. Number: 013.0
Title: Visual Acuity and Ambyopia Screening device
Principal Investigator: Mark Borchert
Patents: 6,402,320
Detailed non-confidential summary

Research Tools

Childrens Hospital Los Angeles Ref. Number: 2007-008
Title: "Transgenic Mouse Model for Medulloblastoma"
Principal Investigator: Gregory Shackleford 

Stem Cell Biology and Gene Therapy

Childrens Hospital Los Angeles Ref. Number: 012.0
Title: Gene therapy by administration of genetically engineered
CD34.sup.+ cells obtained from cord blood
Principal Investigator: Donald B. Kohn
Patents: 6,984,379
Detailed non-confidential summary

Childrens Hospital Los Angeles Ref. Number: 030.0
Title: Minimal Lentiviral Vector System
Principal Investigator: Paula Cannon
Patents: US application No. 11/003,967 and PCT application
Detailed non-confidential summary

4650 Sunset Blvd Los Angeles, CA 90027  |  (323) 660-2450  |  Webmaster Email